Table 2. Adjusted hazard ratios and 95% confidence intervals for episodes of SARS-CoV-2 infection by comorbidities and individual socioeconomic status, Catalonia, Spain, 30 April 2020.
| Characteristics | Adjusted hazard ratio | Lower 0.95 CI | Upper 0.95 CI | p value |
|---|---|---|---|---|
| Hypertension | 0.93 | 0.68 | 1.27 | 0.65 |
| Diabetes | 1.17 | 0.81 | 1.70 | 0.40 |
| Heart failure | 1.24 | 0.76 | 2.04 | 0.40 |
| COPD | 1.59 | 1.08 | 2.35 | 0.01 |
| Chronic renal disease | 1.30 | 0.87 | 1.95 | 0.20 |
| Asthma | 1.19 | 0.78 | 1.82 | 0.40 |
| Dementia | 4.33 | 2.61 | 7.17 | < 0.001 |
| Liver cirrhosis | 0.70 | 0.10 | 5.03 | 0.72 |
| Stroke | 1.38 | 0.88 | 2.16 | 0.16 |
| Coronary artery disease | 1.27 | 0.77 | 2.10 | 0.35 |
| Cancer | 1.05 | 0.73 | 1.52 | 0.79 |
| Current smoker | 0.67 | 0.46 | 0.93 | 0.03 |
| Former smoker | 1.32 | 0.95 | 1.82 | 0.10 |
| IS level < 18,000 € | 1.04 | 0.55 | 1.99 | 0.90 |
| IS level 18,001–100,000 € | 0.85 | 0.44 | 1.68 | 0.60 |
| IS level > 100,000 € | 0.79 | 0.10 | 6.17 | 0.80 |
| CQ/HCQ exposure | 1.08 | 0.83 | 1.44 | 0.50 |
CI: confidence interval; COPD: chronic obstructive pulmonary disease; CQ/HCQ: chloroquine/hydroxychloroquine; IS level: individual socioeconomic level; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.